Groupe Cycle Cellulaire, UMR 6061 Génétique et Développement, CNRS Université de Rennes I, IFR 97 Génomique Fonctionnelle et Santé, Faculté de Médecine, 2 avenue du Pr Léon Bernard, CS 34317, 35043 Rennes cedex, France
* Present address: University of Cambridge, Department of Genetics, Downing Street, Cambridge, CB2 3EH, UK
Author for correspondence (e-mail: claude.prigent{at}univ-rennes1.fr)
Accepted March 15, 2001
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: AuroraA, Xenopus, Centrosome, Spindle, Localisation
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
AuroraB localises to the midbody and its activity is required for cytokinesis (Tatsuka et al., 1998; Terada et al., 1998; Bischoff et al., 1998; Shindo et al., 1998). In C. Elegans auroraB (Air-2) phosphorylation of histone H3 serine 10 is necessary for its mitotic functions (Hsu et al., 2000). Although H3 is the only known substrate of auroraB, many interacting proteins have been identified. AuroraB is a chromosome passenger, and is targeted to the central spindle by interacting with INCENP (Adams et al., 2000; Kaitna et al., 2000); its localisation depends also on the presence of a survivin-like protein (Speliotes et al., 2000) and it seems to interact with a mitotic kinesin-like protein involved in cytokinesis (Severson et al., 2000).
AuroraC also localises to the centrosome but only during anaphase, and its function remains to be determined (Kimura et al., 1999). Several studies have reported an exclusive germline expression for auroraC (Bernard et al., 1998; Tseng et al., 1998; Hu et al., 2000).
The three human kinases share a very conserved C-terminal catalytic domain but each of them possesses an N-terminal domain that is different in size and in sequence (Giet and Prigent, 1999). The non-catalytic domains of protein kinases fulfil at least two functions in vivo: to regulate the kinase activity and to localise the protein. Regulation of the catalytic activity via the non-catalytic domain is found in calcium/calmodulin kinases (CaMK) (Parissenti et al., 1998; Pearson et al., 1988; Goldberg et al., 1996), protein kinase C (PKC) (House and Kemp, 1987; Newton, 1995; Parissenti et al., 1998; Makowske and Rosen, 1989) and polo-like kinases (PLK) (Mundt et al., 1997; Lee and Erikson, 1997). Non-catalytic domains of protein kinases also serve as localisation domains to target the catalytic activity to restricted areas of the cell with precise timing during cell cycle progression. The localisation domain can be an associated protein, as for cAMP-dependent protein kinases (PKA) (Chen et al., 1997; Miki and Eddy, 1998) and the cyclin-dependent kinases (cdk), (Ookata et al., 1995; Cassimeris et al., 1999; Jackman et al., 1995), or the non-catalytic domain of the kinase, as in, for example, the polo-like kinases (Glover et al., 1998; Lee et al., 1998; Arnaud et al., 1998; Song et al., 2000).
There is circumstantial evidence that the localisation of the aurora kinase proteins may depend upon the non-catalytic domain of the kinase. The expression of human auroraA in the yeast Ipl1ts mutant aggravated the Ipl1 phenotype at the permissive temperature, whereas the Ipl1ts phenotype was partially rescued by a hybrid kinase comprising the Ipl1p non-catalytic domain fused to the human auroraA catalytic domain (Bischoff et al., 1998). These results seem to indicate that the human kinase N-terminal domain cannot be used in yeast.
In this report, we have investigated the function of the non-catalytic domain of the Xenopus laevis auroraA kinase pEg2, which is the orthologue of the oncogenic human kinase auroraA (aurora2). We present evidence that the N-terminal domain is essential for the localisation of the kinase in the cell.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Antibodies
Two mouse monoclonal antibodies raised against pEg2-(His)6 were used. The 1C1 antibody recognises the endogenous pEg2 and the recombinant histidine-tagged protein, while the 6E3 antibody only detects the recombinant histidine-tagged proteins (Giet and Prigent, 1998). Both 1C1 and 6E3 antibodies were affinity purified on protein G-Sepharose beads (Amersham Pharmacia Biotech) using standard methods (Harlow and Lane, 1988). Antibodies fixed to the beads were washed with PBS (136 mM NaCl, 26 mM KCl, 2 mM Na2HPO4, 2 mM KH2PO4, pH 7.2) and eluted with 100 mM glycine, pH 2.9, and the fractions were collected in tubes containing 0.1 volume of 1 M Tris/HCl, pH 10. The antibodies were then diluted in 10 mM Hepes, 100 mM KCl and 2 mM MgCl2, and concentrated using a centricon 30 (Amicon) to 3-4 mg/ml. Antibodies were stored at 80°C. The rabbit anti-XlEg5 polyclonal antibody was a gift from Dr Anne Blangy. The rabbit anti--tubulin polyclonal antibody was a gift from Dr Michel Bornens (Institut Curie, Paris, France). The mouse anti-ß-tubulin monoclonal antibody (clone Tub2.1) was purchased from Sigma Chemicals.
Cell culture and transfection
For indirect immunofluorescence studies, Xenopus XL2 cells (embryonic cell line) (Anizet et al., 1981) were cultured on glass coverslips as previously described (Uzbekov et al., 1998). Cells were washed with PBS, fixed in cold methanol (6 minutes at 20°C) and stored at 20°C until used. For transfection, XL2 cells were subcultured on 22-mm diameter glass coverslips in 60-mm plastic Petri dishes, and transfection was carried out using Transfast transfection kit from Promega following the manufacturers instructions. The cells were cultured for 36 hours post-transfection prior to fixation.
Purification of recombinant proteins
All recombinant proteins were expressed in E. coli strain BL21(DE3)pLysS. Histidine-tagged pEg2 proteins were purified on Ni-NTA-agarose beads (Qiagen S.A.) as described previously (Roghi et al., 1998) and the pMAL peptide was purified on amylose resin following the manufacturers instructions (New England Biolabs). For use in spindle assembly and stability assays, proteins were diluted in 10 mM Hepes, 100 mM KCl and 2 mM MgCl2, and concentrated using centricon 10 (Amicon) to 4 mg/ml. The proteins were then stored at 80°C.
Protein kinase assay
The assays were performed in 10 µl of 50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM DTT, 10 mM MgCl2, and 10 µM ATP containing 0.5 µCi of [-32P]dATP (3000 Ci/mmole; Amersham Pharmacia Biotech) containing 200 ng of pEg2-(His)6 and 4 µg of myelin basic protein (MBP) (Sigma Chemicals) in the presence of increasing amounts of either pEg2-K/R-(His)6 or Nt-pEg2-(His)6 proteins. The reactions were incubated at 37°C for 15 minutes, terminated by addition of 10 µl 2x Laemmli sample buffer (Laemmli, 1970) and heated at 90°C for 10 minutes. The proteins were then separated by SDS-polyacrylamide gel electrophoresis. The MBP band was cut out and the associated radioactivity determined by phosphoimager counting (Molecular Dynamics).
Affinity chromatography
The recombinant proteins were overexpressed in a 1 l bacterial culture and purified by affinity chromatography. The bacterial lysate was loaded onto a 200 µl Ni-NTA agarose column following the manufacturers instructions (Qiagen S.A.). The column was extensively washed with PBS and loaded with 500 µl of Xenopus CSF extract prepared as previously described (Roghi et al., 1998). The column was again extensively washed with PBS, eluted using 250 mM imidazole and 200 µl fractions collected. 200 µl 2x Laemmli buffer was added to each fraction and heated for 10 minutes at 90°C. Proteins were separated by SDS-polyacrylamide gel electrophoresis, transferred onto nitrocellulose membrane and identified by western blot analysis.
Western blot analysis
SDS-polyacrylamide gel electrophoresis and electrotransfer of proteins onto nitrocellulose were performed as previously described (Roghi et al., 1998). Membranes were blocked in TBST (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween 20) containing 5% skimmed milk for 2 hours at 4°C, and incubated with the antibodies in TBST containing 2.5% skimmed milk for 1 hour at 4°C. Both 1C1 and 6E3 antibodies were used at 1:100 dilution and anti-XlEg5 at a dilution of 1:1000. Immunocomplexes were identified using either peroxidase or phosphatase-conjugated secondary antibodies (Sigma Chemicals) and chemiluminescence (Amersham Pharmacia Biotech), according to the manufacturers instructions, or using NBT/BCIP (Sigma Chemicals) as the phosphatase substrate.
Microtubule co-pelleting assay
100 ng of purified recombinant protein was incubated for 30 minutes at 37°C in 50 µl of BRB80 (80 mM Pipes, 1 mM MgCl2, 1 mM EGTA, pH 6.8) containing 4 mM MgCl2, 4 mM ATP, 4 mM GTP, 0.4 µg/µl bovine brain tubulin, 100 mM NaCl and 20 µM paclitaxel (in the control experiment the bovine brain tubulin was replaced by bovine serum albumin). After centrifugation at 37°C on a BRB80 glycerol cushion (BRB80, 50% glycerol, 10 µM paclitaxel, 2 mM GTP) at 100,000 g for 20 minutes, the pellets were resuspended in 60 µl 1x Laemmli sample buffer and 10 µl 6x Laemmli sample buffer were added to the 50 µl supernatant.
Co-pelleting assays were performed in 200 µl of high speed supernatant of Xenopus egg CSF extract containing ATPmix regenerator (10 mM creatine phosphate, 80 µg/ml creatine kinase, 2 mM ATP, 1 mM MgCl2), 250 ng of Nt-pEg2-(His)6 and 20 µM of paclitaxel or 10 µg/ml nocodazole. After 30 minutes at 23°C, the reaction mixtures were centrifuged at 23°C through a BRB80 glycerol cushion at 100,000 g for 20 minutes and the pellets and supernatant fractions processed as described previously. The protein fractions were heated for 10 minutes at 90°C, separated by SDS-polyacrylamide gels electrophoresis, transferred onto nitrocellulose membranes and analysed by western blotting.
Spindle assembly and stability assay
Spindles were assembled as described previously (Roghi et al., 1998) using Xenopus egg CSF extracts. Briefly, sperm nuclei (200/µl) were incubated in a CSF extract (20 µl) for 15 minutes at 23°C and activated by the addition of CaCl2 (0.4 mM). Bovine brain rhodamine-labelled tubulin from Tebu (0.4 µg/ml final concentration) was added to the extract to visualise the microtubules. After 60 minutes, the extract was driven into mitosis and arrested in metaphase by the addition of 20 µl of CSF extract containing 16 µg of purified Nt-pEg2-(His)6 (400 ng/µl final concentration) or 16 µg of pMAL peptide. Once metaphase plates had formed (60-70 minutes after addition of the CSF extract), samples were fixed and mounted in a solution containing 15 mM Pipes, 80 mM KCl, 15 mM NaCl, 5 mM EDTA, 7.4% formaldehyde, 5 mM MgCl2, 50% glycerol and 1 µg/µl of bis-benzymide and a minimum of 100 nuclei were scored. Each experiment was repeated 3 times.
To examine bipolar spindle stability, 4 µg of the purified recombinant protein was added to 10 µl of a metaphase spindle containing extract. After 60 minutes of incubation, nuclei were fixed, mounted as described previously, and scored under a DMRXA fluorescence microscope; the images were acquired with a black and white camera and treated with a Leica-Q-Fish program.
Indirect immunofluorescence
Green fluorescent protein (GFP)-transfected cells were fixed for 10 minutes in 75% methanol, 3.7% formaldehyde, 0.5x PBS, washed for 2 minutes with PBS containing 0.1% Triton X-100 and incubated for 1 hour in PBS containing 3% BSA at 20°C. Cells were incubated with the rabbit anti--tubulin antibodies (dilution 1:1000) for 1 hour at 20°C in PBS containing 1% BSA.
-tubulin was detected as described before using Texas Red-conjugated goat anti-rabbit antibody from Sigma Chemicals (diluted 1:1000 in PBS containing 1% BSA and 0.5 µg/ml Hoechst dye).
For immunolocalisation experiments in Xenopus extracts, the extracts were diluted 50 times in 80 mM Pipes, 2 mM MgCl2, 2 mM EDTA, 15% glycerol, loaded onto 4 ml of the dilution buffer and centrifuged onto glass coverslips at 5000 g for 30 minutes at 23°C. After 6 minutes post-fixation in methanol at 20°C the coverslips were incubated in PBS containing 3% BSA for 1 hour at 4°C, followed by an incubation with 6E3 monoclonal (dilution 1:50) or 1C1 monoclonal (dilution 1:50) for 1 hour at 4°C in PBS containing 1% BSA (PBS/BSA). After incubation with fluorescein isothiocyanate-conjugated goat anti-mouse antibody (Sigma Chemicals) in PBS/BSA containing 0.5 µg/ml Hoechst dye for 1 hour at 4°C, the reactions were mounted in PBS containing anti-fade and 50% glycerol and observed under a Leica DMRXA fluorescence microscope.
Centrosome binding assay in vitro
Sperm heads were incubated for 15 minutes at room temperature in mitotic extract (high speed supernatant) containing 400 ng/µl of Nt-pEg2-(His)6. Microtubule nucleation was monitored using rhodamine-labelled tubulin. Samples were diluted 50 times in BRB80 containing 15% glycerol, centrifuged onto glass coverslips, fixed for 6 minutes in cold methanol and processed for immunofluorescence as previously described. Endogenous pEg2 was detected with 1C1 monoclonal antibody and recombinant Nt-pEg2-(His)6 with 6E3 monoclonal antibody; Immunocomplexes were visualised using Texas Red-conjugated goat anti-mouse antibody. Centrosomes were detected with a rabbit anti -tubulin polyclonal antibody and with fluorescein isothyocyanate-conjugated goat anti-rabbit antibody. DNA was stained with Hoechst. The same experiment was repeated in the presence of 20 µM nocodazole.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Microtubules were polymerised in vitro from bovine brain tubulin in the presence of paclitaxel and recombinant proteins Nt-pEg2-(His)6 or pEg2-(His)6 (Fig. 3). After polymerisation, the reaction mixture was centrifuged through a glycerol cushion at 37°C. The pellet containing microtubules and microtubule associated proteins, and the supernatant containing proteins that have no affinity for the microtubules, were analysed for the presence of the recombinant proteins by western blotting. Control experiments were performed in which the bovine brain tubulin was replaced by bovine serum albumin (Fig. 3, lanes 1 and 2). In this case both the full-length kinase and the N-terminal domain remained in the soluble fraction (Fig. 3B,D, lane 1). When bovine brain tubulin was used the full-length kinase was detected only in the pellet fraction, indicating that it strongly associates with the microtubules (Fig. 3B, lane 4). In contrast, in the same conditions, only a small fraction of the N-terminal domain was found to be bound to the microtubules (Fig. 3D, lane 4) while a vast majority of the protein remains in the soluble fraction (Fig. 3D, lane 4).
|
|
|
Because the catalytic domain of pEg2 was insoluble when expressed as a fusion protein in bacteria, we were unable to assay its affinity for the centrosome in Xenopus egg extract. We instead fused this catalytic domain to GFP (Cd-GFP) and expressed it in XL2 cells. Like the N-terminal domain, the catalytic domain was able to localise the GFP to the centrosomes (Fig. 5K). However a statistical analysis of the number of transfected cells containing GFP labelling of the centrosomes, revealed that there were about three times more cells containing Nt-GFP decorated centrosomes than Cd-GFP decorated centrosomes. This showed that, compared to the catalytic domain, there was a threefold increase in the efficiency of the N-terminal domain to localise the GFP to the centrosomes (Fig. 6, white bars).
|
The N-terminal domain of pEg2 inhibits bipolar spindle assembly and destabilises previously assembled bipolar spindles in Xenopus egg extracts
Clues about the function of the N-terminal domain of pEg2 came when we investigated the role of pEg2 in spindle assembly and spindle stability. We planned to use this domain as a control in the experiments and it turned out that in both assays the N-terminal domain of pEg2 shown a dominant negative effect. First we added the recombinant Nt-pEg2-(His)6 to the bipolar spindle assembly assay in Xenopus egg extract, as described previously (Roghi et al., 1998). The extract containing the N-terminal domain of pEg2 showed a decrease in the number of the bipolar spindles assembled. Instead of being bipolar (Fig. 7A, top), the majority of the abnormal spindles observed were monopolar (Fig. 7A, bottom). A quantitative measure of the assembly (Fig. 7B) clearly demonstrated an inhibitory effect of the N-terminal domain (34±18% of the spindles remained bipolar instead of 81±12% in the control).
|
The N-terminal domain of pEg2 was not as efficient in inhibiting either the bipolar spindle assembly or spindle stability as the inactive form of the recombinant kinase, which allowed only 11% of the spindle to assemble bipolar structures and 14% of spindles to remain bipolar (Giet and Prigent, 2000). The effect of the N-terminal domain is comparable to the effect of the addition of the non-inhibitory anti-pEg2 1C1 mAb, which maps to an epitope in the N-terminal domain of the protein (Giet and Prigent, 2000). Because the N-terminal domain does not affect the kinase activity of pEg2 in vitro we assume that the dominant negative effect of the domain observed in the extracts is due to a localisation competition with the endogenous kinase.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We have investigated the function of the non-catalytic domain of the Xenopus auroraA protein (pEg2) and found that this domain localises the kinase to the centrosomes in a microtubule-dependent manner. Using an in situ assay (Giet and Prigent, 1998), we estimated the affinity of the protein for the centrosome at the spindle poles. Whereas the pEg2-(His)6 protein is removed from the centrosome by 300 mM NaCl, only 150 mM NaCl is required to remove Nt-pEg2-(His)6 (data not shown), suggesting that the N-terminal domain has less affinity for the centrosome than the full-length kinase. In fact both the N-terminal domain and the catalytic domain of pEg2, when fused to the GFP, localise to centrosomes when transfected into Xenopus cells. However, again the efficiency of the N-terminal domain to localise to centrosomes is threefold higher. We think that the localisation mechanisms of the two domains are different. The N-terminal domain uses an active mechanism that needs microtubules, whereas the catalytic domain binds directly to the kinase substrates already located at the centrosome. The kinesin-related protein XlEg5, for instance, which is a substrate for pEg2, localises in vivo to mitotic centrosomes after pEg2, during cell cycle progression. The catalytic domain of the kinase associates with XlEg5 through the two-hybrid system (Giet et al., 1999) whereas the N-terminal domain does not bind to this motor protein.
One possible localisation mechanism for the full-length pEg2 is that the kinase might be targeted via its N-terminal domain to the centrosomes where it then finds and/or waits for its substrates. Functionally, this localisation mechanism would bring the kinase close to substrate with which it can interact. Once the catalytic domain binds to the substrate, the affinity of pEg2 for the centrosome increases; that was observed in situ: 150 mM NaCl was required to release the Nt-pEg2-(His)6, versus 300 mM for the full-length kinase (Giet and Prigent, 1998).
Fig. 8 shows one possible mechanism for pEg2 localisation. In the absence of any substrate, pEg2 kinase would localise to the centrosomes via its N-terminal domain through interaction with a hypothetical microtubule binding protein. Then, when the substrate localises to the centrosome the kinase interacts with it. We suggest that the full-length kinase is targeted to the centrosomes via its Nt-domain and the localisation is stabilised by interaction with substrates like XlEg5. XlEg5 localisation in the centrosome is microtubule independent (data not shown).
|
In human cells three different aurora kinases (pEg2 homologues) are localised on the mitotic apparatus: auroraA at the spindle poles and the centrosomes, auroraB at the midbody and auroraC at the centrosomes only in anaphase (Shindo et al., 1998; Terada et al., 1998; Kimura et al., 1999). Each of these three kinases has a conserved catalytic domain (80% identities between auroraB and auroraC), but a very different non-catalytic domain.
It will now be important to determine if the non-catalytic domains of the three human kinases are also localisation domains. The localisation mechanism of auroraB in C elegans, for instance, is quite complex, depending on three proteins, the chromosome passenger INCENP, the survivin-like protein Bir-1 and the mitotic kinesin-related protein Zen-4, with none of these appearing to be auroraB substrates (Adams et al., 2000; Severson et al., 2000; Speliotes et al., 2000).
Because mitosis is very short and extremely dynamic the mechanisms that determine protein localisation to the mitotic apparatus are predicted to result from transient association. The dissection of these localisation mechanisms will be of a great help to our understanding of chromosome segregation.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Adams, R. R., Wheatley, S. P., Gouldsworthy, A. M., Kandels-Lewis, S. E., Carmena, M., Smythe, C., Gerloff, D. L. and Earnshaw, W. C. (2000). INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow Curr. Biol. 10, 1075-1078.
Andresson, T. and Ruderman, J. V. (1998). The kinase Eg2 is a component of the Xenopus oocyte progesterone-activated signaling pathway. EMBO J. 17, 5627-37.
Anizet, M. P., Huwe, B., Pays, A. and Picard, J. J. (1981). Characterization of a new cell line, XL2, obtained from Xenopus laevis and determination of optimal culture conditions. In Vitro 17, 267-274.[Medline]
Arnaud, L., Pines, J. and Nigg, E. A. (1998). GFP tagging reveals human Polo-like kinase 1 at the kinetochore/centromere region of mitotic chromosomes. Chromosoma 107, 424-429.[Medline]
Bernard, M., Sanseau, P., Henry, C., Couturier, A. and Prigent. C. (1998). Cloning of STK13, a third human protein kinase related to drosophila aurora and budding yeast Ipl1 that maps on chromosome 19q13.3-ter. Genomics 53, 406-409.[Medline]
Bischoff, J. R., Anderson, L., Zhu, Y., Mossie, K., Ng, L., Souza, B., Schryver, B., Flanagan, P., Clairvoyant, F., Ginther, C., Chan, C. S., Novotny, M., Slamon, D. J. and Plowman, G. D. (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052-3065.
Bischoff, J. R. and Plowman G. D. (1999). The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol. 9, 454-459.[Medline]
Cassimeris, L. (1999). Accessory protein regulation of microtubule dynamics throughout the cell cycle. Curr. Opin. Cell Biol. 11, 134-141.[Medline]
Chen, Q., Lin, R. Y. and Rubin, C. S. (1997). Organelle-specific targeting of protein kinase AII (PKAII). Molecular and in situ characterization of murine A kinase anchor proteins that recruit regulatory subunits of PKAII to the cytoplasmic surface of mitochondria. J. Biol. Chem. 272, 15247-15257.
Chretien, D., Buendia, B., Fuller, S. D. and Karsenti, E. (1997). Reconstruction of the centrosome cycle from cryoelectron micrographs. Struct. Biol. 120, 117-133.
Felix, M. A., Antony, C., Wright, M. and Maro, B. (1994). Centrosome assembly in vitro: role of gamma-tubulin recruitment in Xenopus sperm aster formation. J. Cell Biol. 124, 19-31.[Abstract]
Francisco, L., Wang, W. and Chan, C. S. (1994). Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol. Cell. Biol. 14, 4731-4740.[Abstract]
Frank-Vaillant, M., Haccard, O., Thibier, C., Ozon, R., Arlot-Bonnemains, Y., Prigent, C. and Jessus, C. (2000) Progesterone regulates the accumulation and the activation of Eg2 kinase in Xenopus oocytes. J. Cell Sci. 113, 1127-1138.
Gaglio, T., Saredi, A., Bingham, J. B., Hasbani, M. J., Gill, S. R., Schroer, T. A. and Compton, D. A. (1996). Opposing motor activities are required for the organization of the mammalian mitotic spindle pole. J. Cell Biol. 135, 399-414.[Abstract]
Giet, R. and Prigent, C. (1998). A Method for in Situ Mitotic Spindle Binding Assay. Exp. Cell Res. 244, 470-473.[Medline]
Giet, R. and Prigent, C. (2000). The Xenopus laevis aurora/Ipl1p-related kinase pEg2 participates in the stability of the bipolar mitotic spindle. Exp. Cell Res. 258, 145-151.[Medline]
Giet, R. and Prigent, C. (1999). Aurora/Ipl1-Related Kinases, a new oncogenic family of mitotic serine-threonine kinases. J. Cell Sci. 112, 3591-3601.
Giet, R., Uzbekov, R., Cubizolles, F., Le Guellec, K. and Prigent, C. (1999). The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5. J. Biol. Chem. 274, 15005-15013.
Glover, D. M., Hagan, I. M. and Tavares, A. A. M. (1998). Polo-like kinases: a team that plays throughout mitosis. Genes Dev. 12, 3777-3787.
Glover, D. M., Leibowitz, M. H., McLean, D. A. and Parry H. (1995). Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 81, 95-105.[Medline]
Goldberg, J., Nairn, A. C. and Kuriyan, J. (1996). Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell 84, 875-887.[Medline]
Harlow, E. and Lane, D. (1998). Antibody, A Laboratory Manual. Cold Spring Harbor laboratory, 726 pp.
Heath, I. B. (1981). Nucleus-associated organelles in fungi. Int. Rev. Cytol., pp. 191-221. Academic Press, New York.
House, C. and Kemp, B. E. (1987). Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238, 1726-1728.[Medline]
Hsu, J.-Y., Sun, Z-W., Li, X., Reuben, M., Tatchell, K., Bishop, D. K., Grushcow, J. M., Brame, C. J., Caldwell, J. A., Hunt, D. F., Lin, R., Smith, M. M. and Allis, C. D. (2000). Mitotic Phosphorylation of Histone H3 Is Governed by Ipl1/aurora Kinase and Glc7/PP1 Phosphatase in Budding Yeast and Nematodes. Cell 102, 279-291.[Medline]
Hu, H.-M., Chuang, C.-K., Lee, M.-J., Tseng, T.-C. and Tang, T. K. (2000). Genomic organization, expression, and chromosome localization of a third aurora-related kinase gene, Aie1. DNA Cell Biol. 19, 679-688.[Medline]
Jackman, M., Firth, M. and Pines, J. (1995). Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J. 14, 1646-1654.[Abstract]
Kaitna, S., Mendoza, M., Jantsch-Plunger, V. and Glotzer, M. (2000). Incenp and an aurora-like kinase form a complex essential for chromosome segregation and efficient completion of cytokinesis. Curr. Biol. 10, 1172-81.[Medline]
Kimura, M., Matsuda, Y., Yoshioka, T. and Okano Y. (1999). Cell Cycle-dependent Expression and Centrosome Localization of a Third Human Aurora/Ipl1-related Protein Kinase, AIK3. J. Biol. Chem. 274, 7334-7340.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.[Medline]
Lee, K. S. and Erikson, R. L. (1997). Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Mol. Cell. Biol. 17, 3408-3417.[Abstract]
Lee, K. S., Grenfell, T. Z., Yarm, F. R. and Erikson, R. L. (1998). Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc. Natl. Acad. Sci. USA 95, 9301-9306.
Makowske, M. and Rosen, O. M. (1989). Complete activation of protein kinase C by an antipeptide antibody directed against the pseudosubstrate prototope. J. Biol. Chem. 264, 16155-16159.
Mendez, R., Hake, L. E., Andresson, T., Littlepage, L. E., Ruderman, J. V. and Richter, J. D. (2000). Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature, 404, 302-307.[Medline]
Merdes, A., Heald, R., Samejima, K., Earnshaw, W. C. and Cleveland, D. W. (2000). Formation of spindle poles by dynein/dynactin-dependent transport of NuMA. J. Cell Biol 149, 851-862.
Miki, K. and Eddy, E. M. (1998). Identification of tethering domains for protein kinase A type Ialpha regulatory subunits on sperm fibrous sheath protein FSC1. J. Biol. Chem. 273, 34384-34390.
Mundt, K. E., Golsteyn, R. M., Lane, H. A. and Nigg, E. A. (1997). On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem. Biophys. Res. Commun. 239, 377-385.[Medline]
Newton, A. C. (1995). Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270, 28495-28498.
Ookata, K., Hisanaga, S., Bulinski, J. C., Murofushi, H., Aizawa, H., Itoh, T. J., Hotani, H., Okumura, E., Tachibana, K. and Kishimoto, T. (1995). Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell Biol. 128, 849-862.[Abstract]
Paintrand, M., Moudjou, M., Delacroix, H. and Bornens, M. (1992). Centrosome organization and centriole architecture: their sensitivity to divalent cations. J. Struct. Biol. 108, 107-128.[Medline]
Parissenti, A. M., Kirwan, A. F., Kim, S. A., Colantonio, C. M. and Schimmer B. P. (1998). Inhibitory properties of the regulatory domains of human protein kinase Calpha and mouse protein kinase Cepsilon. J. Biol. Chem. 273, 8940-8945.
Pearson, R. B., Wettenhall, R. E., Means, A. R., Hartshorne, D. J. and Kemp, B. E. (1998). Autoregulation of enzymes by pseudosubstrate prototopes: myosin light chain kinase. Science 241, 970-973.
Prigent, C., Gill, R., Trower, M. and Sanseau, P. (1998). In silico cloning of a new protein kinase, Aik2, related to Drosophila Aurora using the new tool: EST Blast. In Silico Biology 01, 0011 http://www.bioinfo.de/isb/1998/01/0011/.
Roghi, C., Giet, R., Uzbekov, R., Morin, N., Chartrain, I., Le Guellec, R., Couturier, A., Doree, M., Philippe, M. and Prigent, C. (1998). The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. J. Cell Sci. 111, 557-572.
Sen, S., Zhou, H. and White, R. A. (1997). A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14, 2195-2200.[Medline]
Severson, A. F., Hamill, D. R., Carter, J. C., Schumacher, J. and Bowerman, B. (2000). The aurora-related kinase AIR-2 recruits ZEN-4/CeMKLP1 to the mitotic spindle at metaphase and is required for cytokinesis. Curr. Biol. 10, 1162-1171.[Medline]
Shindo, M., Nakano, H., Kuroyanagi, H., Shirasawa, T., Mihara, M., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Yagita, H. and Okumura, K. (1998). cDNA cloning, expression, subcellular localization, and chromosomal assignment of mammalian aurora homologues, aurora-related kinase (ARK) 1 and 2. Biochem. Biophys. Res. Commun. 244, 285-292.[Medline]
Snyder, M. (1994). The spindle pole body of yeast. Chromosoma. 103, 369-380.[Medline]
Song, S., Grenfell, T., Garfield, S., Erikson, R. L. and Lee, K. S. (2000). Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures. Mol. Cell Biol. 20, 286-298.
Speliotes, E. K., Uren, A., Vaux, D. and Horvitz, H. R. (2000). The survivin-like C. elegans BIR-1 protein acts with the aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol. Cell 6, 211-223.[Medline]
Stearns, T. and Kirschner, M. (1994). In vitro reconstitution of centrosome assembly and function: the central role of gamma-tubulin. Cell 76, 623-637.[Medline]
Tanaka, T., Kimura, M., Matsunaga, K., Fukada, D., Mori, H. and Okano, Y. (1999). Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 59, 2041-2044.
Tatsuka, M., Katayama, H., Ota, T., Tanaka, T., Odashima, S., Suzuki, F. and Terada, Y. (1998). Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 58, 4811-4816.[Abstract]
Terada, Y., Tatsuka, M., Suzuki, F., Yasuda, Y., Fujita, S. and Otsu M. (1998). AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J. 17, 667-676.
Tseng, T. C., Chen, S. H., Hsu, Y. P. and Tang, T. K. (1998). Protein kinase profile of sperm and eggs: cloning and characterization of two novel testis-specific protein kinases (AIE1, AIE2) related to yeast and fly chromosome segregation regulators. DNA Cell Biol. 17, 823-833.[Medline]
Uzbekov, R., Chartrain, I., Philippe, M. and Arlot-Bonnemains, Y. (1998). Cell cycle analysis and synchronization of the Xenopus cell line XL2. Exp. Cell Res. 242, 60-68.[Medline]
Walczak, C. E., Vernos, I., Mitchison, T. J., Karsenti, E. and Heald, R. (1998). A model for the proposed roles of different microtubule-based motor proteins in establishing spindle bipolarity. Curr. Biol. 8, 903-913.[Medline]
Winey M. and Byers, B. (1993). Assembly and functions of the spindle pole body in budding yeast. Trends Genet. 9, 300-304.[Medline]
Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R. and Sen S. (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20, 189-193.[Medline]